Evidence map›Paper›PMID 28066707›Full record

ArticleNeuroImage. Clinical2017

Longitudinal changes in microstructural white matter metrics in Alzheimer's disease.

Chantel D Mayo, Erin L Mazerolle, Lesley Ritchie, John D Fisk, Jodie R Gawryluk, Alzheimer's Disease Neuroimaging Initiative

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in NeuroImage. Clinical, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05020626 (Modelling Tau Deposition and Distribution From Diffusion Tensor Imaging With Generative Adversarial Network for Alzheimer's Disease Diagnosis), which is not on this map. Cited by 97 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed, 2 pooled it
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05020626 recruitingnot on this mapstarted 2021, after this paper: background citation

Modelling Tau Deposition and Distribution From Diffusion Tensor Imaging With Generative Adversarial Network for Alzheimer's Disease Diagnosis

TypeobservationalSponsorChinese University of Hong KongRan2021 to 2025Enrolled250ConditionsAlzheimer's Disease Diagnosis
3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 2 syntheses or guidelines pooled it, 162 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. A phase 2A/B randomized trial of metabolic modulators intranasal insulin and empagliflozin for MCI and early AD.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Probabilistic mapping and automated segmentation of human brainstem white matter bundles.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Longitudinal diffusion tensor imaging correlates with amyloid burden in Down syndrome.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  18. Article
  19. Dissection of Neurotropic Theiler's Murine Encephalomyelitis Virus Induced Brain Atrophy in Single MHC Class I Mice of C57BL/6 Background.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  20. Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Chantel D MayoDepartment of Psychology, University of Victoria, PO Box 1700 STN CSC, Victoria, BC V8W 2Y2, Canada.
Erin L MazerolleDepartment of Radiology and the Hotchkiss Brain Institute, University of Calgary, HSC 2905, 3330 Hospital Dr NW, Calgary, AB T2N 1N4, Canada.
Lesley RitchieDepartment of Clinical Health Psychology, University of Manitoba, 350-771 Bannatyne Avenue, Winnipeg, MB R3E 3N4, Canada.
John D FiskPsychology, Nova Scotia Health Authority, Queen Elizabeth II Health Centre, 4066, 4th Floor, Abbie J. Lane Memorial Building, 5909 Veterans' Memorial Lane, Halifax, NS B3H 2E2, Canada; Department of Psychiatry, Dalhousie University, 4066, Abbie J. Lane Memorial Building, 5909 Veterans' Memorial Lane, Halifax, NS B3H 2E2, Canada; Department of Psychology & Neuroscience, Dalhousie University, 4066, Abbie J. Lane Memorial Building, 5909 Veterans' Memorial Lane, Halifax, NS B3H 2E2, Canada; Department of Medicine, Dalhousie University, 4066, Abbie J. Lane Memorial Building, 5909 Veterans' Memorial Lane, Halifax, NS B3H 2E2, Canada.
Jodie R GawrylukDepartment of Psychology, University of Victoria, PO Box 1700 STN CSC, Victoria, BC V8W 2Y2, Canada.
Alzheimer's Disease Neuroimaging Initiative
University of Victoria · CADalhousie University · CAUniversity of Calgary · CAUniversity of Manitoba · CA

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
CIHRNIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

backgroundAlzheimer's disease (AD) is a progressive neurodegenerative disorder. Current avenues of AD research focus on pre-symptomatic biomarkers that will assist with early diagnosis of AD. The majority of magnetic resonance imaging (MRI) based biomarker research to date has focused on neuronal loss in grey matter and there is a paucity of research on white matter.

methodsLongitudinal DTI data from the Alzheimer's Disease Neuroimaging Initiative 2 database were used to examine 1) the within-group microstructural white matter changes in individuals with AD and healthy controls at baseline and year one; and 2) the between-group microstructural differences in individuals with AD and healthy controls at both time points.

results1) Within-group: longitudinal Tract-Based Spatial Statistics revealed that individuals with AD and healthy controls both had widespread reduced fractional anisotropy (FA) and increased mean diffusivity (MD) with changes in the hippocampal cingulum exclusive to the AD group. 2) Between-group: relative to healthy controls, individuals with AD had lower FA and higher MD in the hippocampal cingulum, as well as the corpus callosum, internal and external capsule; corona radiata; posterior thalamic radiation; superior and inferior longitudinal fasciculus; fronto-occipital fasciculus; cingulate gyri; fornix; uncinate fasciculus; and tapetum.

conclusionThe current results indicate that sensitivity to white matter microstructure is a promising avenue for AD biomarker research. Additional longitudinal studies on both white and grey matter are warranted to further evaluate potential clinical utility.

Indexed as

Disease ProgressionAgedAged, 80 and overAlzheimer DiseaseBiomarkersDatabases, FactualDiffusion Tensor ImagingFemaleHumansLongitudinal StudiesMaleWhite MatterBiomarkersAD, Alzheimer's diseaseADNI, Alzheimer's Disease Neuroimaging InitiativeAgingAlzheimer's diseaseDiffusion tensor imagingDTI, diffusion tensor imagingFA, fractional anisotropyFSL, Functional MRI of the Brain Software LibraryHC, healthy controlsMagnetic resonance imagingMCI, mild cognitive impairmentMD, mean diffusivityMMSE, Mini Mental Status ExamMRI, magnetic resonance imagingROI, region of interestTBSS, Tract-Based Spatial StatisticsWhite matterWMS, Wechsler Memory Scale

Identifiers

PMID28066707
PMCPMC5200876
OpenAlexW2566061819

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.